BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $367,000 | -53.7% | 2,425 | -55.4% | 0.03% | -51.4% |
| Q2 2022 | $792,000 | +23.0% | 5,435 | 0.0% | 0.07% | +48.9% |
| Q1 2022 | $644,000 | -14.0% | 5,435 | 0.0% | 0.05% | -2.1% |
| Q4 2021 | $749,000 | -24.9% | 5,435 | -24.4% | 0.05% | -34.2% |
| Q3 2021 | $998,000 | +43.2% | 7,185 | 0.0% | 0.07% | +49.0% |
| Q2 2021 | $697,000 | +42.0% | 7,185 | 0.0% | 0.05% | +28.9% |
| Q1 2021 | $491,000 | -26.2% | 7,185 | -7.4% | 0.04% | -19.1% |
| Q4 2020 | $665,000 | +38.3% | 7,760 | +4.9% | 0.05% | +23.7% |
| Q3 2020 | $481,000 | -3.2% | 7,400 | +8.8% | 0.04% | -13.6% |
| Q2 2020 | $497,000 | – | 6,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |